Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roche
Pharma
As Imbruvica fails, Brukinsa wins FDA nod in follicular lymphoma
With the first follicular lymphoma nod for a BTK inhibitor, BeiGene's Brukinsa will go up against CAR-T cell therapies and bispecifics.
Angus Liu
Mar 7, 2024 4:08pm
FDA approves Roche, Novartis' Xolair for common food allergies
Feb 16, 2024 2:28pm
Leqembi, Takeda, Roche—Fierce Pharma Asia
Feb 9, 2024 9:02am
Roche's answer to AstraZeneca PNH drugs nabs China nod
Feb 8, 2024 11:02am
Novartis CEO's pay rises 21% as Roche's new chief nets $11M
Feb 5, 2024 1:28pm
The top 10 biopharma M&A deals of 2023
Feb 5, 2024 3:00am